首页 > 最新文献

Texas Heart Institute Journal最新文献

英文 中文
Periprocedural Risk Predictors Affecting Long-Term Prognosis in Patients With Chronic Obstructive Pulmonary Disease Undergoing Coronary Artery Bypass Grafting. 影响冠状动脉旁路移植术慢性阻塞性肺病患者长期预后的围手术期风险预测因子
IF 0.9 4区 医学 Pub Date : 2024-03-18 DOI: 10.14503/THIJ-23-8199
Aleksander Dokollari, Serge Sicouri, Leila Hosseinian, Ozgun Erten, Basel Ramlawi, Gianluigi Bisleri, Massimo Bonacchi, Noah Sicouri, Gianluca Torregrossa, Francis P Sutter

Objective: This study sought to identify periprocedural risk predictors that affect long-term prognosis in patients with chronic obstructive pulmonary disease (COPD) undergoing isolated coronary artery bypass grafting (CABG).

Methods: All consecutive 4,871 patients undergoing isolated CABG between May 2005 and June 2021 were included. Patients with and without COPD were compared for baseline demographics and preoperative characteristics. A propensity-matched analysis was used to compare the 2 groups. The primary outcome was long-term incidence of all-cause death.

Results: After matching, 767 patients each were included in the COPD and non-COPD groups; mean age was 71.6 and 71.4 years (P = .7), respectively; 29.3% and 32% (P = .2) were women, respectively. Intraoperatively, median (IQR) operating room time was higher in the COPD group than in the non-COPD group (5.9 [5.2-7.0] hours vs 5.8 [5.1-6.7] hours, respectively; P = .01). Postoperatively, intensive care unit stay (P = .03), hospital length of stay (P = .0004), and fresh frozen plasma transfusion units (P = .012) were higher in the COPD group than in the non-COPD group. Thirty-day mortality was not different between groups (1.3% in the COPD group vs 1% in the non-COPD group; P = .4). Median follow-up time was 4.0 years. The rate of all-cause death was higher in the COPD group than in the non-COPD group (138 patients [18.3%] vs 109 patients [14.5%], respectively; P = .042). Periprocedural risk predictors for all-cause death in patients with COPD were atrial fibrillation, diabetes, male sex, dialysis, ejection fraction less than 50%, peripheral vascular disease, and Society of Thoracic Surgeons Predicted Risk of Mortality score greater than 4%.

Conclusion: Patients with COPD undergoing isolated CABG had a significantly higher incidence of all-cause death than those without COPD. Herein, risk predictors are provided for all-cause death in patients undergoing isolated CABG.

研究目的本研究旨在确定影响接受孤立冠状动脉旁路移植术(CABG)的慢性阻塞性肺病(COPD)患者长期预后的围手术期风险预测因素:方法:纳入2005年5月至2021年6月期间连续接受分离式冠状动脉旁路移植术的4871名患者。对患有和未患有慢性阻塞性肺病的患者进行基线人口统计学和术前特征比较。采用倾向匹配分析对两组患者进行比较。主要结果是全因死亡的长期发生率:匹配后,慢性阻塞性肺病组和非慢性阻塞性肺病组各有 767 名患者;平均年龄分别为 71.6 岁和 71.4 岁(P = .7);女性分别占 29.3% 和 32% (P = .2)。术中,慢性阻塞性肺病组的手术室时间中位数(IQR)高于非慢性阻塞性肺病组(分别为 5.9 [5.2-7.0] 小时 vs 5.8 [5.1-6.7] 小时;P = .01)。术后,慢性阻塞性肺病组的重症监护室住院时间(P = .03)、住院时间(P = .0004)和新鲜冰冻血浆输注单位(P = .012)均高于非慢性阻塞性肺病组。慢性阻塞性肺病组与非慢性阻塞性肺病组的 30 天死亡率没有差异(慢性阻塞性肺病组为 1.3%,非慢性阻塞性肺病组为 1%;P = .4)。中位随访时间为 4.0 年。慢性阻塞性肺病组的全因死亡率高于非慢性阻塞性肺病组(分别为 138 名患者 [18.3%] vs 109 名患者 [14.5%];P = .042)。COPD患者全因死亡的围手术期风险预测因素包括心房颤动、糖尿病、男性、透析、射血分数小于50%、外周血管疾病以及胸外科医师协会预测死亡风险评分大于4%:结论:接受孤立CABG手术的慢性阻塞性肺病患者的全因死亡发生率明显高于非慢性阻塞性肺病患者。本文提供了接受孤立的 CABG 患者全因死亡的风险预测指标。
{"title":"Periprocedural Risk Predictors Affecting Long-Term Prognosis in Patients With Chronic Obstructive Pulmonary Disease Undergoing Coronary Artery Bypass Grafting.","authors":"Aleksander Dokollari, Serge Sicouri, Leila Hosseinian, Ozgun Erten, Basel Ramlawi, Gianluigi Bisleri, Massimo Bonacchi, Noah Sicouri, Gianluca Torregrossa, Francis P Sutter","doi":"10.14503/THIJ-23-8199","DOIUrl":"10.14503/THIJ-23-8199","url":null,"abstract":"<p><strong>Objective: </strong>This study sought to identify periprocedural risk predictors that affect long-term prognosis in patients with chronic obstructive pulmonary disease (COPD) undergoing isolated coronary artery bypass grafting (CABG).</p><p><strong>Methods: </strong>All consecutive 4,871 patients undergoing isolated CABG between May 2005 and June 2021 were included. Patients with and without COPD were compared for baseline demographics and preoperative characteristics. A propensity-matched analysis was used to compare the 2 groups. The primary outcome was long-term incidence of all-cause death.</p><p><strong>Results: </strong>After matching, 767 patients each were included in the COPD and non-COPD groups; mean age was 71.6 and 71.4 years (P = .7), respectively; 29.3% and 32% (P = .2) were women, respectively. Intraoperatively, median (IQR) operating room time was higher in the COPD group than in the non-COPD group (5.9 [5.2-7.0] hours vs 5.8 [5.1-6.7] hours, respectively; P = .01). Postoperatively, intensive care unit stay (P = .03), hospital length of stay (P = .0004), and fresh frozen plasma transfusion units (P = .012) were higher in the COPD group than in the non-COPD group. Thirty-day mortality was not different between groups (1.3% in the COPD group vs 1% in the non-COPD group; P = .4). Median follow-up time was 4.0 years. The rate of all-cause death was higher in the COPD group than in the non-COPD group (138 patients [18.3%] vs 109 patients [14.5%], respectively; P = .042). Periprocedural risk predictors for all-cause death in patients with COPD were atrial fibrillation, diabetes, male sex, dialysis, ejection fraction less than 50%, peripheral vascular disease, and Society of Thoracic Surgeons Predicted Risk of Mortality score greater than 4%.</p><p><strong>Conclusion: </strong>Patients with COPD undergoing isolated CABG had a significantly higher incidence of all-cause death than those without COPD. Herein, risk predictors are provided for all-cause death in patients undergoing isolated CABG.</p>","PeriodicalId":48680,"journal":{"name":"Texas Heart Institute Journal","volume":"51 1","pages":""},"PeriodicalIF":0.9,"publicationDate":"2024-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11075519/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140144398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endovascular Strategies for Aortic Arch When US Food and Drug Administration-Approved Devices Are Not Available. 当无法获得美国食品和药物管理局批准的设备时,主动脉弓的血管内治疗策略。
IF 0.9 4区 医学 Pub Date : 2024-03-14 DOI: 10.14503/THIJ-24-8391
Gabrielle Sutton, Rana Afifi
{"title":"Endovascular Strategies for Aortic Arch When US Food and Drug Administration-Approved Devices Are Not Available.","authors":"Gabrielle Sutton, Rana Afifi","doi":"10.14503/THIJ-24-8391","DOIUrl":"10.14503/THIJ-24-8391","url":null,"abstract":"","PeriodicalId":48680,"journal":{"name":"Texas Heart Institute Journal","volume":"51 1","pages":""},"PeriodicalIF":0.9,"publicationDate":"2024-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11075481/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140121112","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Resolution of Severe Portopulmonary Hypertension With Inhaled Treprostinil and Liver Transplantation. 通过吸入曲普瑞替尼和肝移植缓解严重的肺门高压症
IF 0.9 4区 医学 Pub Date : 2024-03-14 DOI: 10.14503/THIJ-23-8209
Alex J Chang, Choon Hwa Goh

Portopulmonary hypertension is a rare condition with a poor prognosis. Prompt management is essential for liver transplantation eligibility, a potentially curative option. This report presents a case of severe portopulmonary hypertension that resolved with a conservative therapeutic regimen of tadalafil, macitentan, and inhaled treprostinil, which ultimately enabled successful liver transplantation. There was no recurrence of pulmonary hypertension after transplantation, and the patient was weaned off most pulmonary arterial hypertension therapies. This case report is the first to provide evidence that inhaled treprostinil is a safe and effective alternative to continuous intravenous prostacyclins in portopulmonary hypertension.

肺动脉高压是一种罕见的疾病,预后不良。及时处理对获得肝移植资格至关重要,而肝移植是一种潜在的治疗方案。本报告介绍了一例严重的门静脉肺动脉高压患者,该患者在接受了他达拉非、马西坦坦和吸入曲普瑞替尼的保守治疗方案后,病情得到缓解,最终成功进行了肝移植。移植后,肺动脉高压没有复发,患者也脱离了大部分肺动脉高压治疗。本病例报告首次提供了证据,证明吸入曲普瑞替尼可安全有效地替代持续静脉注射前列环素治疗门静脉肺动脉高压。
{"title":"Resolution of Severe Portopulmonary Hypertension With Inhaled Treprostinil and Liver Transplantation.","authors":"Alex J Chang, Choon Hwa Goh","doi":"10.14503/THIJ-23-8209","DOIUrl":"10.14503/THIJ-23-8209","url":null,"abstract":"<p><p>Portopulmonary hypertension is a rare condition with a poor prognosis. Prompt management is essential for liver transplantation eligibility, a potentially curative option. This report presents a case of severe portopulmonary hypertension that resolved with a conservative therapeutic regimen of tadalafil, macitentan, and inhaled treprostinil, which ultimately enabled successful liver transplantation. There was no recurrence of pulmonary hypertension after transplantation, and the patient was weaned off most pulmonary arterial hypertension therapies. This case report is the first to provide evidence that inhaled treprostinil is a safe and effective alternative to continuous intravenous prostacyclins in portopulmonary hypertension.</p>","PeriodicalId":48680,"journal":{"name":"Texas Heart Institute Journal","volume":"51 1","pages":""},"PeriodicalIF":0.9,"publicationDate":"2024-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11075503/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140121113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Successful Suture-Free Repair of Left Ventricular Rupture Using the EVARREST Patch. 使用 EVARREST 补片成功完成左心室破裂的无缝合修复术
IF 0.9 4区 医学 Pub Date : 2024-03-07 DOI: 10.14503/THIJ-23-8277
Paighton C Miller, Linda J Schulte, Kunal Kotkar

Left ventricular free wall rupture is a lethal complication of myocardial infarction. Although emergent surgical repair is the treatment of choice, the method of repair remains highly individualized. This report presents a case of spontaneous coronary artery dissection in a patient with Turner syndrome that led to left ventricular free wall rupture and was successfully repaired on cardiopulmonary bypass using a suture-free technique with the EVARREST Fibrin Sealant Patch.

左心室游离壁破裂是心肌梗死的致命并发症。尽管紧急手术修复是首选治疗方法,但修复方法仍高度个性化。本报告介绍了一例特纳综合征患者自发性冠状动脉夹层导致左心室游离壁破裂的病例,该患者在心肺旁路手术中使用 EVARREST 纤维蛋白密封补片无缝合技术成功修复了左心室游离壁。
{"title":"Successful Suture-Free Repair of Left Ventricular Rupture Using the EVARREST Patch.","authors":"Paighton C Miller, Linda J Schulte, Kunal Kotkar","doi":"10.14503/THIJ-23-8277","DOIUrl":"10.14503/THIJ-23-8277","url":null,"abstract":"<p><p>Left ventricular free wall rupture is a lethal complication of myocardial infarction. Although emergent surgical repair is the treatment of choice, the method of repair remains highly individualized. This report presents a case of spontaneous coronary artery dissection in a patient with Turner syndrome that led to left ventricular free wall rupture and was successfully repaired on cardiopulmonary bypass using a suture-free technique with the EVARREST Fibrin Sealant Patch.</p>","PeriodicalId":48680,"journal":{"name":"Texas Heart Institute Journal","volume":"51 1","pages":""},"PeriodicalIF":0.9,"publicationDate":"2024-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11075498/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140060911","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How to Assess the Feasibility of a Second Transcatheter Aortic Valve Replacement When the First Valve Fails. 当第一次主动脉瓣置换术失败时,如何评估第二次经导管主动脉瓣置换术的可行性?
IF 0.9 4区 医学 Pub Date : 2024-02-13 DOI: 10.14503/THIJ-23-8301
Stephanie Tom, John Lisko, Kendra J Grubb
{"title":"How to Assess the Feasibility of a Second Transcatheter Aortic Valve Replacement When the First Valve Fails.","authors":"Stephanie Tom, John Lisko, Kendra J Grubb","doi":"10.14503/THIJ-23-8301","DOIUrl":"10.14503/THIJ-23-8301","url":null,"abstract":"","PeriodicalId":48680,"journal":{"name":"Texas Heart Institute Journal","volume":"51 1","pages":""},"PeriodicalIF":0.9,"publicationDate":"2024-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11075484/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139724589","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bypass Grafts in Women: What Is the Gold Standard? 女性旁路移植:什么是黄金标准?
IF 0.9 4区 医学 Pub Date : 2024-02-12 DOI: 10.14503/THIJ-23-8238
Natalia Roa-Vidal, Lauren K Barron
{"title":"Bypass Grafts in Women: What Is the Gold Standard?","authors":"Natalia Roa-Vidal, Lauren K Barron","doi":"10.14503/THIJ-23-8238","DOIUrl":"10.14503/THIJ-23-8238","url":null,"abstract":"","PeriodicalId":48680,"journal":{"name":"Texas Heart Institute Journal","volume":"51 1","pages":""},"PeriodicalIF":0.9,"publicationDate":"2024-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11075513/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139724587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Insights From the Histopathologic Analysis of Acquired and Genetic Thoracic Aortic Aneurysms and Dissections. 后天性和遗传性胸主动脉瘤和夹层的组织病理学分析启示。
IF 0.9 4区 医学 Pub Date : 2024-02-12 DOI: 10.14503/THIJ-23-8253
L Maximilian Buja, Bihong Zhao, Humaira Sadaf, Michelle McDonald, Ana M Segura, Li Li, Alana Cecchi, Siddharth K Prakash, Rana O Afifi, Charles C Miller, Anthony L Estrera, Dianna M Milewicz

Objective: The purpose of this study was to apply contemporary consensus criteria developed by the Society for Cardiovascular Pathology and the Association for European Cardiovascular Pathology to the evaluation of aortic pathology, with the expectation that the additional pathologic information may enhance the understanding and management of aortic diseases.

Methods: A scoring system was applied to ascending aortic specimens from 42 patients with heritable thoracic aortic disease and known genetic variations and from 86 patients from a single year, including patients with known genetic variations (n = 12) and patients with sporadic disease (n = 74).

Results: The various types of lesions of medial degeneration and the overall severity of medial degeneration overlapped considerably between those patients with heritable disease and those with sporadic disease; however, patients with heritable thoracic aortic disease had significantly more overall medial degeneration (P = .004) and higher levels of elastic fiber fragmentation (P = .03) and mucoid extracellular matrix accumulation (P = .04) than patients with sporadic thoracic aortic disease. Heritable thoracic aortic disease with known genetic variation was more prevalent in women than in men (27.2% vs 9.8%; P = .04), and women had more severe medial degeneration than men (P = .04). Medial degeneration scores were significantly lower for patients with bicuspid aortic valves than for patients with tricuspid aortic valves (P = .03).

Conclusion: The study's findings indicate considerable overlap in the pattern, extent, and severity of medial degeneration between sporadic and hereditary types of thoracic aortic disease. This finding suggests that histopathologic medial degeneration represents the final common outcome of diverse pathogenetic factors and mechanisms.

研究目的本研究的目的是将心血管病理协会和欧洲心血管病理协会制定的当代共识标准应用于主动脉病理评估,期望额外的病理信息能增强对主动脉疾病的理解和管理:对42名患有遗传性胸主动脉疾病和已知基因变异的患者以及86名来自同一年的患者(包括已知基因变异患者(12人)和散发性疾病患者(74人))的升主动脉标本采用了评分系统:结果:与散发性胸主动脉疾病患者相比,遗传性胸主动脉疾病患者的各种类型的内侧变性病变和内侧变性的总体严重程度有很大的重叠;但是,遗传性胸主动脉疾病患者的总体内侧变性程度明显高于散发性胸主动脉疾病患者(P = .004),弹性纤维断裂程度(P = .03)和黏液状细胞外基质堆积程度(P = .04)也高于散发性胸主动脉疾病患者。具有已知遗传变异的遗传性胸主动脉疾病在女性中的发病率高于男性(27.2% vs 9.8%;P = .04),女性的内侧变性比男性更严重(P = .04)。双尖瓣主动脉瓣患者的内侧退变评分明显低于三尖瓣主动脉瓣患者(P = .03):研究结果表明,散发性和遗传性胸主动脉疾病在内侧变性的模式、范围和严重程度上有相当大的重叠。这一发现表明,组织病理学上的内侧变性代表了不同致病因素和机制的最终共同结果。
{"title":"Insights From the Histopathologic Analysis of Acquired and Genetic Thoracic Aortic Aneurysms and Dissections.","authors":"L Maximilian Buja, Bihong Zhao, Humaira Sadaf, Michelle McDonald, Ana M Segura, Li Li, Alana Cecchi, Siddharth K Prakash, Rana O Afifi, Charles C Miller, Anthony L Estrera, Dianna M Milewicz","doi":"10.14503/THIJ-23-8253","DOIUrl":"10.14503/THIJ-23-8253","url":null,"abstract":"<p><strong>Objective: </strong>The purpose of this study was to apply contemporary consensus criteria developed by the Society for Cardiovascular Pathology and the Association for European Cardiovascular Pathology to the evaluation of aortic pathology, with the expectation that the additional pathologic information may enhance the understanding and management of aortic diseases.</p><p><strong>Methods: </strong>A scoring system was applied to ascending aortic specimens from 42 patients with heritable thoracic aortic disease and known genetic variations and from 86 patients from a single year, including patients with known genetic variations (n = 12) and patients with sporadic disease (n = 74).</p><p><strong>Results: </strong>The various types of lesions of medial degeneration and the overall severity of medial degeneration overlapped considerably between those patients with heritable disease and those with sporadic disease; however, patients with heritable thoracic aortic disease had significantly more overall medial degeneration (P = .004) and higher levels of elastic fiber fragmentation (P = .03) and mucoid extracellular matrix accumulation (P = .04) than patients with sporadic thoracic aortic disease. Heritable thoracic aortic disease with known genetic variation was more prevalent in women than in men (27.2% vs 9.8%; P = .04), and women had more severe medial degeneration than men (P = .04). Medial degeneration scores were significantly lower for patients with bicuspid aortic valves than for patients with tricuspid aortic valves (P = .03).</p><p><strong>Conclusion: </strong>The study's findings indicate considerable overlap in the pattern, extent, and severity of medial degeneration between sporadic and hereditary types of thoracic aortic disease. This finding suggests that histopathologic medial degeneration represents the final common outcome of diverse pathogenetic factors and mechanisms.</p>","PeriodicalId":48680,"journal":{"name":"Texas Heart Institute Journal","volume":"51 1","pages":""},"PeriodicalIF":0.9,"publicationDate":"2024-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11075520/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139724590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cannula Placement for Cerebral Protection Without Circulatory Arrest in Patients Undergoing Hemiarch Aortic Aneurysm Repair. 在接受半弓主动脉瘤修补术的患者中植入插管以保护大脑而无需停止循环。
IF 0.9 4区 医学 Pub Date : 2024-02-12 DOI: 10.14503/THIJ-22-8026
Joseph C Sweeney, Jaimin R Trivedi, Toyokazu Endo, Akhila Ankem, Siddharth V Pahwa, Mark S Slaughter, Brian L Ganzel

Background: Aortic aneurysms involving the proximal aortic arch, which require hemiarch-type repair, typically require circulatory arrest with antegrade cerebral perfusion. Left carotid antegrade cerebral perfusion (LCP) via distal arch cannulation without circulatory arrest was used in this study's patient population. The goal was to assess the operative efficiency and clinical outcomes of using a distal arch cannulation technique that would not require any hypothermic circulatory arrest (HCA) time compared with more traditional brachiocephalic artery cannulation with right-sided unilateral antegrade cerebral perfusion (RCP) and HCA.

Methods: A single-center retrospective review of patients with replacement of the distal ascending aorta involving the proximal arch was performed. Patients with an intramural hematoma or dissection were excluded. Between January 2015 and December 2019, 68 adult patients had undergone a hemiarch repair because of aneurysmal disease. Analysis of baseline demographics, operative data, and clinical outcomes was performed.

Results: Comparing the 68 patients: 21 patients were treated with RCP (via brachiocephalic artery graft with HCA), and 47 patients were treated with LCP (via distal aortic arch cannulation with cross-clamp between the brachiocephalic and left common carotid arteries without HCA). Baseline characteristics and outcomes were evaluated for both groups. The LCP group was younger (LCP median [IQR] age, 60 [53-65] years vs RCP median [IQR] age, 67 [59-71] years]. Sex, race, body mass index, comorbidities, and ejection fraction were similar between the groups. Cardiopulmonary bypass time (LCP, 123 minutes vs RCP, 149 minutes) and unilateral cerebral perfusion time (LCP, 17 minutes vs RCP, 22 minutes) were longer in the RCP group. Bleeding, prolonged ventilatory support, kidney failure, and length of stay were similar. In-hospital mortality was 2% in the LCP group vs 0% in the RCP group. Stroke occurred in 2 patients (4.2%) in the LCP group and in 0% of the RCP group. Mortality at 6 months in the LCP and RCP groups was 3% and 10%, respectively.

Conclusion: Distal arch cannulation with LCP without HCA is a reasonable and safe alternative strategy for patients requiring hemiarch replacement for aneurysmal disease. This technique may provide additional benefits by avoiding circulatory arrest in these complex cases.

背景:涉及主动脉弓近端、需要半弓型修复的主动脉瘤通常需要停循环并进行逆行脑灌注。本研究在患者中采用了通过远端主动脉弓插管进行左侧颈动脉逆行脑灌注(LCP),无需停循环。目的是评估与更传统的右侧单侧前向脑灌注(RCP)和 HCA 的肱动脉插管相比,无需低体温停循环(HCA)时间的远端足弓插管技术的手术效率和临床效果:对涉及近端弓的远端升主动脉置换患者进行了单中心回顾性研究。排除了有壁内血肿或夹层的患者。2015年1月至2019年12月期间,68名成年患者因动脉瘤疾病接受了半弓修补术。对基线人口统计学、手术数据和临床结果进行了分析:对 68 名患者进行了比较:结果:对 68 名患者进行了比较:21 名患者接受了 RCP(通过带 HCA 的肱动脉移植)治疗,47 名患者接受了 LCP(通过主动脉弓远端插管,交叉夹闭肱动脉和左侧颈总动脉,不带 HCA)治疗。对两组患者的基线特征和疗效进行了评估。LCP 组较年轻(LCP 中位[IQR]年龄为 60 [53-65] 岁 vs RCP 中位[IQR]年龄为 67 [59-71] 岁)。两组患者的性别、种族、体重指数、合并症和射血分数相似。RCP组的心肺旁路时间(LCP,123分钟 vs RCP,149分钟)和单侧脑灌注时间(LCP,17分钟 vs RCP,22分钟)更长。出血、呼吸机支持时间延长、肾衰竭和住院时间相似。LCP 组的院内死亡率为 2%,而 RCP 组为 0%。LCP 组有 2 名患者(4.2%)发生中风,而 RCP 组为 0%。LCP组和RCP组6个月的死亡率分别为3%和10%:对于因动脉瘤疾病需要进行半弓置换术的患者来说,使用 LCP 进行远端弓插管而不使用 HCA 是一种合理而安全的替代策略。在这些复杂病例中,该技术可避免循环骤停,从而带来更多益处。
{"title":"Cannula Placement for Cerebral Protection Without Circulatory Arrest in Patients Undergoing Hemiarch Aortic Aneurysm Repair.","authors":"Joseph C Sweeney, Jaimin R Trivedi, Toyokazu Endo, Akhila Ankem, Siddharth V Pahwa, Mark S Slaughter, Brian L Ganzel","doi":"10.14503/THIJ-22-8026","DOIUrl":"10.14503/THIJ-22-8026","url":null,"abstract":"<p><strong>Background: </strong>Aortic aneurysms involving the proximal aortic arch, which require hemiarch-type repair, typically require circulatory arrest with antegrade cerebral perfusion. Left carotid antegrade cerebral perfusion (LCP) via distal arch cannulation without circulatory arrest was used in this study's patient population. The goal was to assess the operative efficiency and clinical outcomes of using a distal arch cannulation technique that would not require any hypothermic circulatory arrest (HCA) time compared with more traditional brachiocephalic artery cannulation with right-sided unilateral antegrade cerebral perfusion (RCP) and HCA.</p><p><strong>Methods: </strong>A single-center retrospective review of patients with replacement of the distal ascending aorta involving the proximal arch was performed. Patients with an intramural hematoma or dissection were excluded. Between January 2015 and December 2019, 68 adult patients had undergone a hemiarch repair because of aneurysmal disease. Analysis of baseline demographics, operative data, and clinical outcomes was performed.</p><p><strong>Results: </strong>Comparing the 68 patients: 21 patients were treated with RCP (via brachiocephalic artery graft with HCA), and 47 patients were treated with LCP (via distal aortic arch cannulation with cross-clamp between the brachiocephalic and left common carotid arteries without HCA). Baseline characteristics and outcomes were evaluated for both groups. The LCP group was younger (LCP median [IQR] age, 60 [53-65] years vs RCP median [IQR] age, 67 [59-71] years]. Sex, race, body mass index, comorbidities, and ejection fraction were similar between the groups. Cardiopulmonary bypass time (LCP, 123 minutes vs RCP, 149 minutes) and unilateral cerebral perfusion time (LCP, 17 minutes vs RCP, 22 minutes) were longer in the RCP group. Bleeding, prolonged ventilatory support, kidney failure, and length of stay were similar. In-hospital mortality was 2% in the LCP group vs 0% in the RCP group. Stroke occurred in 2 patients (4.2%) in the LCP group and in 0% of the RCP group. Mortality at 6 months in the LCP and RCP groups was 3% and 10%, respectively.</p><p><strong>Conclusion: </strong>Distal arch cannulation with LCP without HCA is a reasonable and safe alternative strategy for patients requiring hemiarch replacement for aneurysmal disease. This technique may provide additional benefits by avoiding circulatory arrest in these complex cases.</p>","PeriodicalId":48680,"journal":{"name":"Texas Heart Institute Journal","volume":"51 1","pages":""},"PeriodicalIF":0.9,"publicationDate":"2024-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11075151/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139724588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interventional Treatment Options for the Prevention of Amputation in Patients With Lower Extremity Wounds From Peripheral Arterial Disease. 预防外周动脉疾病下肢伤口患者截肢的介入治疗方案。
IF 0.9 4区 医学 Pub Date : 2024-02-07 DOI: 10.14503/THIJ-23-8240
Akin Torun, Ulas Bildirici

Background: Peripheral arterial disease and related lower extremity wounds are prominent causes of amputation. Revascularization may reduce amputation rates or the amputation margin more distally in patients with peripheral arterial disease who have wounds resulting from critical limb ischemia. This study examined the association of risk factors and intervention types with amputation rates in patients with critical lower extremity arterial disease.

Methods: A total of 211 patients who underwent peripheral intervention because of foot wound were followed up for 12 months after the intervention. All patients had lower extremity wounds resulting from peripheral arterial disease. The effects of treatment approaches were compared in patients who underwent and did not undergo amputation.

Results: Revascularization of the anterior tibial artery reduced the amputation rate by 6.52 times compared with occlusion. Posterior tibial artery revascularization reduced the amputation rate by 49.95 times.

Conclusion: In this study of percutaneous intervention methods for prevention of amputation, the most effective option was revascularization of the posterior tibial artery and anterior tibial artery. Considering these results, treatment of critical peripheral arterial disease can be cost-effective and efficient and may shorten procedure time.

背景:外周动脉疾病和相关的下肢伤口是截肢的主要原因。对于肢体严重缺血导致伤口的外周动脉疾病患者,血管再通术可能会降低截肢率或缩小截肢范围。本研究探讨了危重下肢动脉疾病患者的风险因素和干预类型与截肢率的关系:共对 211 名因足部伤口接受外周介入治疗的患者进行了介入治疗后 12 个月的随访。所有患者的下肢伤口均由外周动脉疾病引起。比较了截肢和未截肢患者的治疗效果:结果:与闭塞相比,胫前动脉血管重建可将截肢率降低 6.52 倍。胫后动脉再通术使截肢率降低了49.95倍:在这项关于预防截肢的经皮介入方法的研究中,最有效的方案是胫后动脉和胫前动脉再血管化。考虑到这些结果,治疗危重外周动脉疾病既经济又有效,还能缩短手术时间。
{"title":"Interventional Treatment Options for the Prevention of Amputation in Patients With Lower Extremity Wounds From Peripheral Arterial Disease.","authors":"Akin Torun, Ulas Bildirici","doi":"10.14503/THIJ-23-8240","DOIUrl":"10.14503/THIJ-23-8240","url":null,"abstract":"<p><strong>Background: </strong>Peripheral arterial disease and related lower extremity wounds are prominent causes of amputation. Revascularization may reduce amputation rates or the amputation margin more distally in patients with peripheral arterial disease who have wounds resulting from critical limb ischemia. This study examined the association of risk factors and intervention types with amputation rates in patients with critical lower extremity arterial disease.</p><p><strong>Methods: </strong>A total of 211 patients who underwent peripheral intervention because of foot wound were followed up for 12 months after the intervention. All patients had lower extremity wounds resulting from peripheral arterial disease. The effects of treatment approaches were compared in patients who underwent and did not undergo amputation.</p><p><strong>Results: </strong>Revascularization of the anterior tibial artery reduced the amputation rate by 6.52 times compared with occlusion. Posterior tibial artery revascularization reduced the amputation rate by 49.95 times.</p><p><strong>Conclusion: </strong>In this study of percutaneous intervention methods for prevention of amputation, the most effective option was revascularization of the posterior tibial artery and anterior tibial artery. Considering these results, treatment of critical peripheral arterial disease can be cost-effective and efficient and may shorten procedure time.</p>","PeriodicalId":48680,"journal":{"name":"Texas Heart Institute Journal","volume":"51 1","pages":""},"PeriodicalIF":0.9,"publicationDate":"2024-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11075502/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139698670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pericardiectomy and Mechanical Mitro-Aortic Valve Replacement in a Young Patient With Erdheim-Chester Disease. 一名年轻的埃尔德海姆-切斯特病患者的心包切除术和机械二尖瓣置换术
IF 0.9 4区 医学 Pub Date : 2024-02-07 DOI: 10.14503/THIJ-23-8201
Nerea Lopez Perez, Mathieu van Steenberghe, Jörg D Seebach, Philippe Meyer, Johannes Alexander Lobrinus, Christoph Huber, Mustafa Cikirikcioglu

Erdheim-Chester disease is a rare histiocytosis that primarily affects the skeletal system, but cardiovascular manifestations occur in 75% of cases and are associated with a poor prognosis. Given the small number of cases, the evolution and management of the disease are uncertain. Therefore, it is important to report and share Erdheim-Chester cases. This report presents the case of a young patient with constrictive pericarditis and mitral valve regurgitation resulting from Erdheim-Chester disease.

埃尔德海姆-切斯特病是一种罕见的组织细胞增生症,主要影响骨骼系统,但 75% 的病例会出现心血管表现,且预后不良。由于病例较少,该病的演变和治疗尚不确定。因此,报告和分享 Erdheim-Chester 病例非常重要。本报告介绍了一例因埃尔德海姆-切斯特病而患有缩窄性心包炎和二尖瓣反流的年轻患者。
{"title":"Pericardiectomy and Mechanical Mitro-Aortic Valve Replacement in a Young Patient With Erdheim-Chester Disease.","authors":"Nerea Lopez Perez, Mathieu van Steenberghe, Jörg D Seebach, Philippe Meyer, Johannes Alexander Lobrinus, Christoph Huber, Mustafa Cikirikcioglu","doi":"10.14503/THIJ-23-8201","DOIUrl":"10.14503/THIJ-23-8201","url":null,"abstract":"<p><p>Erdheim-Chester disease is a rare histiocytosis that primarily affects the skeletal system, but cardiovascular manifestations occur in 75% of cases and are associated with a poor prognosis. Given the small number of cases, the evolution and management of the disease are uncertain. Therefore, it is important to report and share Erdheim-Chester cases. This report presents the case of a young patient with constrictive pericarditis and mitral valve regurgitation resulting from Erdheim-Chester disease.</p>","PeriodicalId":48680,"journal":{"name":"Texas Heart Institute Journal","volume":"51 1","pages":""},"PeriodicalIF":0.9,"publicationDate":"2024-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11075495/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139698671","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Texas Heart Institute Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1